Status | Study |
Recruiting |
Study Name: Familial Investigations of Childhood Cancer Predisposition Condition: Acute Leukemia Adenomatous Polyposis Adrenocortical Carcin Date: 2017-02-08 |
Recruiting |
Study Name: Investigation of the Genetics of Hematologic Diseases Condition: Bone Marrow Failure Syndromes Erythrocyte Disorder Leukocy Date: 2016-03-16 |
Terminated |
Study Name: Related Hematopoietic Stem Cell Transplantation (HSCT) for Genetic Diseases of Blood Cells Condition: Stem Cell Transplantation Bone Marrow Transplantation Peri Date: 2015-05-21 Interventions: Drug: Cyclophosphamide Dose Level 1 |
Completed |
Study Name: L-leucine in Diamond Blackfan Anemia Patients Condition: Diamond Blackfan Anemia Date: 2015-02-18 Interventions: Drug: L-leucine L-leucine pills per os for 6 months |
Recruiting |
Study Name: Safety Study of Gene Modified Donor T Cell Infusion After Stem Cell Transplant for Non-Malignant Diseases Condition: Primary Immune Deficiency Disorders Hemophagocytic Lymphohistiocytosis Date: 2014-08-28 Interventions: Biological: BPX-501 and AP1903 Single administration of BPX-501 T cells post partially-mismatched, relat |
Recruiting |
Study Name: Hematopoietic Stem Cell Transplant for High Risk Hemoglobinopathies Condition: Sickle Cell Disease Transfusion Dependent Alpha- or Beta- Thalassemia Date: 2014-06-27 Interventions: Drug: Reduced Toxicity Ablative Regimen |
Recruiting |
Study Name: CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant Condition: Chronic Myeloid Leukemia (CML) Acute Myelogenous Leukemia (AML); Date: 2014-02-11 Interventions: Device: CliniMACS CD34+ Reagent System |
Recruiting |
Study Name: CD34+ Stem Cell Selection for Patients Receiving Allogeneic Stem Cell Transplantation for Non-Malignant Disease Condition: Bone Marrow Failure Syndrome Severe Aplastic Anemia Severe Date: 2013-10-17 Interventions: Biological: CD34 Stem Cell Selection Therapy The CliniMacs (PLUS) Reagent System (Miltenyi CliniMacs CD3 |
Recruiting |
Study Name: Reduced Intensity Conditioning in Patients Aged ≤35 With Non-Malignant Disorders Undergoing UCBT, BMT, or PBSCT Condition: Primary Immunodeficiency Syndromes Congenital Bone Marrow Failure Syndromes Date: 2013-10-10 Interventions: Drug: Hydroxyurea Hydroxyurea |
Terminated |
Study Name: Multi-Center Study of Iron Overload: Survey Study (MCSIO) Condition: Sickle Cell Disease Thalassemia Diam Date: 2013-07-30 |